A Cluster Package Intervention to Promote an Evidence-based Use of PSA-tests in General Practice
Development and Evaluation of a Cluster Package Intervention to Promote an Evidence-based Use of PSA-tests in General Practice: A Cluster Randomized Trial
University of Copenhagen
50 participants
Sep 9, 2024
INTERVENTIONAL
Conditions
Summary
It is widely acknowledged that prostate specific antigen (PSA) testing can lead to false-positives, overdiagnosis and overtreatment of prostate cancer. The current national clinical guidelines only recommend the test to a small group of patients and does not recommend neither systematic nor opportunistic screening for prostate cancer with the test. The aim of this cluster randomized trial is to evaluate the effectiveness of a complex intervention aimed at improving the use of evidence based practice when using prostate specific antigen tests in general practice. The complex intervention in this study is a so called cluster package which is meeting material to a quality cluster meeting as almost every general practitioner is a member of a quality cluster. Therefore, the investigators have developed a cluster package aimed at promoting an evidence-based use of the prostate specific antigen test to general practitioners.
Eligibility
Inclusion Criteria2
- Quality clusters with a cluster coordinator
- Quality clusters willing to participate in a cluster meeting with PSA as a theme in 2025.
Exclusion Criteria3
- Quality clusters who already planned their cluster meetings in 2025.
- Quality clusters unwilling to await allocation before planning their cluster meetings in 2025.
- Quality clusters participating in the pilot study
Interventions
A pre-recorded podcast with a urologist and a GP discussing the theme to promote preparatory reflections among the GPs before the cluster meeting
A two-hour meeting facilitated by either the GPs cluster coordinator, another GP from the cluster or a facilitator outside the cluster chosen by the cluster itself with specific slides about PSA in general, guidelines, expert videos, data from the clinics, cases, and group discussions
Hand-outs of the main take-home messages to facilitate further discussion in their respective GP offices
Hand-outs to be used by GP and patients to facilitate communication about the relevance of taking a PSA-test
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06748456